文献速递哮喘

轻度哮喘中2型炎症水平不同患者的黏液纤毛清除率差异

Mucociliary Clearance Differs in Mild Asthma by Levels of Type 2 Inflammation.
PubMed 文献 · Chest · 2021-05-21

该研究比较了未使用皮质类固醇的轻度哮喘患者中2型炎症低水平(T2 Lo,n=17)与高水平(T2 Hi,n=18)组的吸入放射性颗粒清除率,并与历史健康对照(HCs,n=12)对比。结果显示T2 Lo组黏液纤毛清除率(MCC)高于T2 Hi组和健康对照,且MCC随2型炎症标志物(CCL26、NOS2、POSTN)及Feno表达升高而下降。提示2型炎症加重与MCC降低相关,T2 Lo组的高MCC可能是轻度疾病的补偿机制。

要点

  • 轻度哮喘T2 Lo组MCC高于T2 Hi组及健康对照。
  • MCC随2型炎症标志物表达和Feno升高而下降。
  • T2 Hi组内MCC变异大,部分患者清除率低或为零。

核心结论

  • 2型炎症加重与轻度哮喘患者黏液纤毛清除率下降相关。
  • T2 Lo组的高MCC可能反映轻度疾病中的补偿机制,高水平炎症时丢失。

研究设计与样本

  • 前瞻性比较轻度哮喘患者T2 Lo(Feno<25 ppb,n=17)与T2 Hi(Feno>35 ppb,n=18)的吸入放射性颗粒清除率。
  • 通过纤维支气管镜采集支气管刷检样本,用定量PCR测量T2哮喘相关基因表达。
  • 与历史健康对照(HCs,n=12)进行MCC率比较。

主要发现

  • T2 Lo组MCC较T2 Hi组和历史HCs增加。
  • T2 Hi组内MCC变异显著,部分受试者清除率低或为零。
  • MCC随CCL26、NOS2、POSTN表达及Feno升高而下降。
  • T2 Lo与T2 Hi组间MUC5AC和FOXJ1表达相似。

临床怎么用

  • 对未用皮质类固醇的轻度哮喘患者,Feno高水平(>35 ppb)提示MCC可能受损。
  • 关注2型炎症标志物表达升高者的黏液清除功能。

局限性

  • 样本量较小,T2 Lo组17例、T2 Hi组18例、健康对照12例。
  • 健康对照为历史组,非同期对照。
  • 机制及MCC受损与临床结局的关系需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although mucus plugging is a well-reported feature of asthma, whether asthma and type 2 inflammation affect mucociliary clearance (MCC) is unknown. RESEARCH QUESTION: Does type 2 inflammation influence mucus clearance rates in patients with mild asthma who are not receiving corticosteroids? STUDY DESIGN AND METHODS: The clearance rates of inhaled radiolabeled particles were compared between patients with mild asthma with low (n = 17) and high (n = 18) levels of T2 inflammation. Fraction exhaled nitric oxide (Feno) was used to prospectively segregate subjects into T2 Lo (Feno < 25 ppb) and T2 Hi (Feno > 35 ppb) cohorts. Bronchial brush samples were collected with fiber-optic bronchoscopy, and quantitative polymerase chain reaction was performed to measure expression of genes associated with T2 asthma. MCC rate comparisons were also made with a historical group of healthy control subjects (HCs, n = 12). RESULTS: The T2 Lo cohort demonstrated increased MCC when compared with both T2 Hi and historic HCs. MCC within the T2 Hi group varied significantly, with some subjects having low or zero clearance. MCC decreased with increasing expression of several markers of T2 airway inflammation (CCL26, NOS2, and POSTN) and with Feno. MUC5AC and FOXJ1 expression was similar between the T2Lo and T2Hi cohorts. INTERPRETATION: Increasing T2 inflammation was associated with decreasing MCC. High rates of MCC in T2 Lo subjects may indicate a compensatory mechanism present in mild disease but lost with high levels of inflammation. Future studies are required to better understand mechanisms and whether impairments in MCC in more severe asthma drive worse clinical outcomes.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Corcoran TE, Huber AS, Hill SL, et al. Mucociliary Clearance Differs in Mild Asthma by Levels of Type 2 Inflammation. Chest. 2021. PMID: 34029561. doi:10.1016/j.chest.2021.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。